Log inSign up
Image
user avatar
Corrixr Therapeutics
@CorriXR
Corrixr is developing a targeted genetic medicine designed to disable NRF2 in lung, head & neck, and esophageal squamous cell cancers.
Newark, DE
corrixr.com
Joined October 2023
25
Following
20
Followers

@CorriXR hasn’t posted

When they do, their posts will show up here.